INR 55.07
(-1.06%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | 129.09 Million INR | -4.84% |
2022 | 135.66 Million INR | 46.35% |
2021 | 93.33 Million INR | 14.45% |
2020 | 62.59 Million INR | 71.95% |
2019 | 28.5 Million INR | 8.25% |
2018 | 34.16 Million INR | 5.46% |
2017 | 37.01 Million INR | -5.58% |
2016 | 44.41 Million INR | 12.07% |
2015 | 38.99 Million INR | 29.19% |
2014 | 29.03 Million INR | 30.3% |
2013 | 23.16 Million INR | 52.66% |
2012 | 15.17 Million INR | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | 28.1 Million INR | -33.19% |
2023 Q1 | 27.68 Million INR | -13.61% |
2023 Q2 | 40.33 Million INR | 45.68% |
2023 Q4 | 46.45 Million INR | 70.04% |
2023 FY | - INR | -4.84% |
2023 Q3 | 27.32 Million INR | -32.26% |
2022 Q4 | 32.05 Million INR | -24.62% |
2022 Q1 | 14.12 Million INR | -54.06% |
2022 Q2 | 46.97 Million INR | 232.62% |
2022 Q3 | 42.51 Million INR | -9.48% |
2022 FY | - INR | 46.35% |
2021 Q2 | 29.63 Million INR | 239.54% |
2021 Q4 | 30.73 Million INR | 42.89% |
2021 Q1 | 8.72 Million INR | -12.09% |
2021 FY | - INR | 14.45% |
2021 Q3 | 21.51 Million INR | -27.4% |
2020 FY | - INR | 71.95% |
2020 Q2 | 16.27 Million INR | 0.0% |
2020 Q3 | 9.92 Million INR | -38.99% |
2020 Q4 | 9.92 Million INR | 0.0% |
2020 Q1 | 16.27 Million INR | 159.35% |
2019 Q4 | 6.27 Million INR | 0.0% |
2019 FY | - INR | 8.25% |
2019 Q2 | 7.97 Million INR | 0.0% |
2019 Q1 | 7.97 Million INR | -42.51% |
2019 Q3 | 6.27 Million INR | -21.35% |
2018 Q4 | 13.87 Million INR | 0.0% |
2018 FY | - INR | 5.46% |
2018 Q3 | 13.87 Million INR | 544.9% |
2018 Q2 | 2.15 Million INR | 0.0% |
2018 Q1 | 2.15 Million INR | -79.75% |
2017 Q3 | 10.62 Million INR | 26.87% |
2017 Q4 | 10.62 Million INR | 0.0% |
2017 FY | - INR | -5.58% |
2017 Q1 | 8.37 Million INR | 0.0% |
2017 Q2 | 8.37 Million INR | 0.0% |
2016 FY | - INR | 12.07% |
2015 FY | - INR | 29.19% |
2014 FY | - INR | 30.3% |
2013 FY | - INR | 52.66% |
2012 FY | - INR | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
Amrutanjan Health Care Limited | 681.59 Million INR | 81.06% |
Biofil Chemicals and Pharmaceuticals Limited | 12.99 Million INR | -893.336% |
Caplin Point Laboratories Limited | 6.18 Billion INR | 97.912% |
FDC Limited | 3.38 Billion INR | 96.187% |
Gufic Biosciences Limited | 1.48 Billion INR | 91.28% |
Hikal Limited | 2.69 Billion INR | 95.205% |
Ind-Swift Laboratories Limited | 6.86 Billion INR | 98.119% |
IOL Chemicals and Pharmaceuticals Limited | 2.6 Billion INR | 95.047% |
Kilitch Drugs (India) Limited | 287.42 Million INR | 55.086% |
Nectar Lifesciences Limited | 1.53 Billion INR | 91.593% |
Par Drugs and Chemicals Limited | 228.17 Million INR | 43.423% |
RPG Life Sciences Limited | 1.28 Billion INR | 89.926% |
Sequent Scientific Limited | 549.8 Million INR | 76.52% |
Shilpa Medicare Limited | 2.58 Billion INR | 95.012% |
Sigachi Industries Limited | 883.39 Million INR | 85.387% |
Themis Medicare Limited | 562.6 Million INR | 77.054% |
Unichem Laboratories Limited | 742.35 Million INR | 82.61% |
Venus Remedies Limited | 711.8 Million INR | 81.864% |
Wanbury Limited | 985.49 Million INR | 86.901% |
ZIM Laboratories Limited | 462.09 Million INR | 72.063% |
Lupin Limited | 36.96 Billion INR | 99.651% |
Innova Captab Limited | 1.66 Billion INR | 92.262% |
Ind-Swift Limited | 1.06 Billion INR | 87.879% |
Bajaj HealthCare Limited | 406.23 Million INR | 68.222% |
Aurobindo Pharma Limited | 61.78 Billion INR | 99.791% |
Solara Active Pharma Sciences Limited | -2.82 Billion INR | 104.575% |
AstraZeneca Pharma India Limited | 2.35 Billion INR | 94.522% |
Mangalam Drugs & Organics Limited | 174.94 Million INR | 26.209% |
Morepen Laboratories Limited | 1.72 Billion INR | 92.52% |
Laurus Labs Limited | 8 Billion INR | 98.388% |
Aarti Drugs Limited | 3.24 Billion INR | 96.026% |
Glenmark Life Sciences Limited | 6.86 Billion INR | 98.119% |
Alembic Limited | 1.11 Billion INR | 88.436% |
Alembic Pharmaceuticals Limited | 9.61 Billion INR | 98.658% |
Glenmark Pharmaceuticals Limited | 11.34 Billion INR | 98.862% |
Vaishali Pharma Limited | 31.71 Million INR | -307.095% |
Aarti Pharmalabs Limited | 3.9 Billion INR | 96.698% |
Jagsonpal Pharmaceuticals Limited | 323.46 Million INR | 60.09% |
Jubilant Pharmova Limited | 8 Billion INR | 98.388% |
Eris Lifesciences Limited | 6.98 Billion INR | 98.152% |
Windlas Biotech Limited | 781.72 Million INR | 83.486% |
Sun Pharmaceutical Industries Limited | 138.36 Billion INR | 99.907% |
Lincoln Pharmaceuticals Limited | 1.34 Billion INR | 90.39% |
Orchid Pharma Limited | 1.41 Billion INR | 90.904% |
Albert David Limited | 1.04 Billion INR | 87.652% |
Hester Biosciences Limited | 539.47 Million INR | 76.07% |
Sakar Healthcare Limited | 393.26 Million INR | 67.174% |
Suven Pharmaceuticals Limited | 4.67 Billion INR | 97.24% |
Procter & Gamble Health Limited | 3.07 Billion INR | 95.801% |
Divi's Laboratories Limited | 25.43 Billion INR | 99.492% |
Mankind Pharma Limited | 28.09 Billion INR | 99.541% |
Neuland Laboratories Limited | 4.74 Billion INR | 97.281% |
J. B. Chemicals & Pharmaceuticals Limited | 9.33 Billion INR | 98.617% |
Zydus Lifesciences Limited | 56.22 Billion INR | 99.77% |
Wockhardt Limited | 1.08 Billion INR | 88.047% |
Bal Pharma Limited | 345.59 Million INR | 62.646% |
Dr. Reddy's Laboratories Limited | 88.27 Billion INR | 99.854% |
Bliss GVS Pharma Limited | 1.47 Billion INR | 91.272% |
Alkem Laboratories Limited | 24.19 Billion INR | 99.466% |
Valiant Laboratories Limited | 12.73 Million INR | -913.376% |
Ajanta Pharma Limited | 12.56 Billion INR | 98.973% |
Bafna Pharmaceuticals Limited | 114.58 Million INR | -12.664% |
Aarey Drugs & Pharmaceuticals Limited | 45.16 Million INR | -185.828% |
Granules India Limited | 8.6 Billion INR | 98.5% |
Medicamen Biotech Limited | 245.66 Million INR | 47.45% |
Ipca Laboratories Limited | 13.29 Billion INR | 99.029% |
Brooks Laboratories Limited | 41.72 Million INR | -209.37% |
Syncom Formulations (India) Limited | 430.27 Million INR | 69.997% |
Piramal Enterprises Limited | -3.86 Billion INR | 103.343% |
Torrent Pharmaceuticals Limited | 35 Billion INR | 99.631% |
NATCO Pharma Limited | 18.79 Billion INR | 99.313% |
Suven Life Sciences Limited | -992.78 Million INR | 113.003% |
Krebs Biochemicals & Industries Limited | -82.72 Million INR | 256.048% |
Strides Pharma Science Limited | 3.76 Billion INR | 96.571% |
Indoco Remedies Limited | 2.64 Billion INR | 95.123% |
Alpa Laboratories Limited | 229.96 Million INR | 43.863% |
Lasa Supergenerics Limited | -65.08 Million INR | 298.362% |
Sun Pharma Advanced Research Company Limited | -3.73 Billion INR | 103.46% |